Previous 10 | Next 10 |
Search all stock news releases related news releases and press releases from US and Canada Markets.
Approval of Reblozyl is based on head-to-head, pivotal Phase 3 COMMANDS study, in which Reblozyl nearly doubled the percentage of patients achieving transfusion independence and hemoglobin increase, along with increased durability compared to epoetin alfa This is the fourt...
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Infinitum Copper Corp. (TSXV:INFI, OTCQB:INUMF) (" Infinitum " or the " Company ") is pleased to announce the details of a proposed consolidation of its common shares. On March 21, 2024, in accordance with the constating documents of the Company, the ...
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Infinitum Copper Corp. (TSXV:INFI, OTCQB:INUMF) (" Infinitum " or the " Company ") is pleased to announce the details of a proposed consolidation of its common shares. On March 21, 2024, in accordance with the constating documents of the Company, the ...
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Infinitum Copper Corp. (TSXV:INFI, OTCQB:INUMF) (" Infinitum " or the " Company ") is pleased to announce the details of a proposed consolidation of its common shares. On March 21, 2024, in accordance with the constating documents of the Company, the ...
2024-04-02 20:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 20:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 20:00:02 ET Dan Levy from Barclays issued a price target of $225.00 for TSLA on 2024-04-02 18:50:00. The adjusted price target was set to $225.00. At the time of the announcement, TSLA was trading at $166.63. The overall price target consensus is at $251.92 wi...
2024-04-02 20:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 20:00:00 ET Beating the market doesn’t have to be a chore for new investors who want more of a set-and-forget type of portfolio. Indeed, truly wonderful businesses don’t require nearly as much constant monitoring as you’d think. With the disruptive impact of ...
2024-04-02 20:00:00 ET Beating the market doesn’t have to be a chore for new investors who want more of a set-and-forget type of portfolio. Indeed, truly wonderful businesses don’t require nearly as much constant monitoring as you’d think. With the disruptive impact of ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
25.58%Change Percent:
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
allarity.com Website: